Literature DB >> 16416215

Coexistence of splenic non-Hodgkin's lymphoma with hepatocellular carcinoma in a patient with chronic hepatitis C.

Takashi Himoto1, Yoshiaki Miyauchi, Kei Nomura, Toshiaki Fushitani, Kazutaka Kurokohchi, Tsutomu Masaki, Akihiro Deguchi, Seiji Nakai, Toshiharu Funaki, Seishiro Watanabe, Reiji Haba, Shigeki Kuriyama.   

Abstract

Entities:  

Mesh:

Year:  2006        PMID: 16416215     DOI: 10.1007/s10620-006-3087-1

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  5 in total

1.  Enlargement of thermal ablation zone by the combination of ethanol injection and radiofrequency ablation in excised bovine liver.

Authors:  Seishiro Watanabe; Kazutaka Kurokohchi; Tsutomu Masaki; Yoshiaki Miyauchi; Toshiharu Funaki; Hideyuki Inoue; Takashi Himoto; Yuko Kita; Naohito Uchida; Tetsuo Touge; Toshiaki Tatsukawa; Shigeki Kuriyama
Journal:  Int J Oncol       Date:  2004-02       Impact factor: 5.650

Review 2.  Hepatocellular carcinoma.

Authors:  K Okuda
Journal:  J Hepatol       Date:  2000       Impact factor: 25.083

3.  Combined use of percutaneous ethanol injection and radiofrequency ablation for the effective treatment of hepatocelluar carcinoma.

Authors:  K Kurokohchi; S Watanabe; T Masaki; N Hosomi; T Funaki; K Arima; S Yoshida; Y Miyauchi; S Kuriyama
Journal:  Int J Oncol       Date:  2002-10       Impact factor: 5.650

4.  Combination therapy of percutaneous ethanol injection and radiofrequency ablation against hepatocellular carcinomas difficult to treat.

Authors:  Kazutataka Kurokohchi; Seishiro Watanabe; Tsutomu Masaki; Naoki Hosomi; Toshiharu Funaki; Keiji Arima; Shuhei Yoshida; Seiji Nakai; Masayuki Murota; Yoshiaki Miyauchi; Shigeki Kuriyama
Journal:  Int J Oncol       Date:  2002-09       Impact factor: 5.650

5.  Efficacy of combination therapies of percutaneous or laparoscopic ethanol-lipiodol injection and radiofrequency ablation.

Authors:  Kazutaka Kurokohchi; Tsutomu Masaki; Yoshiaki Miyauchi; Naoki Hosomi; Hirohito Yoneyama; Shuhei Yoshida; Takashi Himoto; Akihiro Deguchi; Seiji Nakai; Hideyuki Inoue; Seishiro Watanabe; Shigeki Kuriyama
Journal:  Int J Oncol       Date:  2004-12       Impact factor: 5.650

  5 in total
  4 in total

1.  Hepatocellular carcinoma infiltrated with non-Hodgkin's lymphoma: report of a case.

Authors:  Tohru Utsunomiya; Masahiro Okamoto; Eiji Tsujita; Manabu Yamamoto; Shinichi Tsutsui; Megumu Fujihara; Teruyoshi Ishida
Journal:  Surg Today       Date:  2009-11-01       Impact factor: 2.549

2.  Repeat hepatectomies for hepatic malignant lymphoma and hepatocellular carcinoma associated with chronic hepatitis C: report of a case.

Authors:  Hirotada Tajiri; Keishi Sugimachi; Nao Kinjo; Masahiko Ikebe; Junko Tanaka; Kiyoshi Tanaka; Shuichi Tsukamoto; Shinsuke Mii; Eiji Kajiwara; Tatsuro Shimokama; Hidefumi Higashi
Journal:  Surg Today       Date:  2013-02-13       Impact factor: 2.549

3.  Case Report: Clinical Responses to Tislelizumab as a First-Line Therapy for Primary Hepatocellular Carcinoma With B-Cell Indolent Lymphoma.

Authors:  Qijun Li; Yong Dong; Yubin Pan; Honglin Tang; Da Li
Journal:  Front Immunol       Date:  2021-03-31       Impact factor: 7.561

4.  Coexistence of splenic marginal zone lymphoma with hepatocellular carcinoma: a case report.

Authors:  Shu-Hui Zhang; Ai-Min Xu; Jian-Ming Zheng; Miao-Xia He
Journal:  Diagn Pathol       Date:  2007-02-06       Impact factor: 2.644

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.